Dysbiosis and Implication of the Gut Microbiota in Diabetic RetinopathyOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined whether gut microbial dysbiosis differs between diabetic patients with and without retinopathy. Fecal samples were analyzed using 16S ribosomal RNA gene sequencing to characterize microbial structure and composition. The researchers compared microbial diversity and the abundance of specific bacterial genera across the three groups. They also sought to identify a bacterial biomarker set capable of distinguishing diabetic retinopathy from diabetes alone and from healthy controls.
Who was studied?
The study included 75 participants divided into three groups of 25 each. One group consisted of diabetic patients without retinopathy (DM), one of diabetic patients with retinopathy (DR), and one of healthy controls (HC). Clinical information and fecal samples were collected from all participants for microbial analysis.
What were the most important findings?
Microbial structure and composition differed across the three groups, with both the DM and DR groups showing reduced alpha and beta diversity compared with healthy controls. Blautia was the most abundant genus overall, particularly in the DM group. Bifidobacterium and Lactobacillus were increased, while Escherichia-Shigella, Faecalibacterium, Eubacterium_hallii_group, and Clostridium were decreased in the DM and DR groups relative to healthy controls. A biomarker set of 25 bacterial families distinguished DR patients from DM and HC groups, with area under the curve values ranging from 0.69 to 0.85.
What are the greatest implications of this study?
The findings suggest that gut microbial dysbiosis is not uniform across diabetes and diabetic retinopathy, indicating a possible gut-eye axis specific to retinal complications. The identification of a distinguishing bacterial biomarker set raises the possibility of using gut microbiota profiles to help differentiate diabetic patients at risk for retinopathy. These results support further investigation into the gut microbiome as a factor in the pathogenesis of diabetic retinopathy, though the abstract does not establish causation.